Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.

Capella C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, Ye F, Mertz SE, Johnson SM, Moore-Clingenpeel M, Ramilo O, Mejias A, Peeples ME.

J Infect Dis. 2017 Dec 12;216(11):1398-1406. doi: 10.1093/infdis/jix489.

2.

Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O.

J Infect Dis. 2014 Jul 15;210(2):224-33. doi: 10.1093/infdis/jiu079. Epub 2014 Feb 4.

3.

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE.

J Virol. 2010 Nov;84(21):11515-22. doi: 10.1128/JVI.01703-09. Epub 2010 Aug 25. Erratum in: J Virol. 2011 Jan;85(1):650.

4.

Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection.

Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flaño E.

J Virol. 2007 Sep;81(18):9778-89. Epub 2007 Jul 11.

5.

Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.

Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO, Durbin RK, Flaño E, Durbin JE.

J Virol. 2007 Sep;81(18):9790-800. Epub 2007 Jul 11.

6.

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, Jewell NA, Hammond S, Flano E, Durbin RK, García-Sastre A, Durbin JE.

J Virol. 2006 Feb;80(3):1130-9.

7.

Role for innate IFNs in determining respiratory syncytial virus immunopathology.

Johnson TR, Mertz SE, Gitiban N, Hammond S, Legallo R, Durbin RK, Durbin JE.

J Immunol. 2005 Jun 1;174(11):7234-41.

8.

Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.

Gitiban N, Jurcisek JA, Harris RH, Mertz SE, Durbin RK, Bakaletz LO, Durbin JE.

J Virol. 2005 May;79(10):6035-42.

9.

PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent.

Durbin RK, Mertz SE, Koromilas AE, Durbin JE.

Viral Immunol. 2002;15(1):41-51.

PMID:
11952146
10.

The role of IFN in respiratory syncytial virus pathogenesis.

Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS.

J Immunol. 2002 Mar 15;168(6):2944-52.

11.

Tracer technique to measure in vivo chemical transport rates within an implantable cell transplantation device.

Sarver JG, Fournier RL, Goldblatt PJ, Phares TL, Mertz SE, Baker AR, Mellon RJ, Horner JM, Selman SH.

Cell Transplant. 1995 Mar-Apr;4(2):201-17.

PMID:
7539700

Supplemental Content

Loading ...
Support Center